CNS PHARMACEUTICALS INC (CNSP:NASDAQ)
$5.43 0.54 (11.0429%)
Analysed CNS PHARMACEUTICALS INC (CNSP:NASDAQ) News Sources
CNS Pharmaceuticals Announces CEO Transition
17-12-2025
yahoo.com
CNS Pharmaceuticals Issues Letter to Shareholders
27-01-2026
yahoo.com
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
17-02-2026
yahoo.com
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
02-03-2026
yahoo.com
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
11-03-2026
yahoo.com
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
04-05-2026
yahoo.com
Top Midday Gainers
04-05-2026
yahoo.com
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
14-05-2026
yahoo.com
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
14-05-2026
247wallst.com
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
20-05-2026
yahoo.com
What is the current price of CNS PHARMACEUTICALS INC (CNSP:NASDAQ)?
The current price of CNS PHARMACEUTICALS INC (CNSP:NASDAQ) is $5.43.
CNS PHARMACEUTICALS INC (CNSP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CNS PHARMACEUTICALS INC (CNSP:NASDAQ) since the previous trading day is $0.54.
CNS PHARMACEUTICALS INC (CNSP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CNS PHARMACEUTICALS INC (CNSP:NASDAQ) since the previous trading day is 11.0429%.
What is the most recent average sentiment score for CNS PHARMACEUTICALS INC (CNSP:NASDAQ)?
The most recent average sentiment score for CNS PHARMACEUTICALS INC (CNSP:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for CNS PHARMACEUTICALS INC (CNSP:NASDAQ)?
The most recent sentiment for CNS PHARMACEUTICALS INC (CNSP:NASDAQ) is .
SEC-8K** Filing Available For CNS PHARMACEUTICALS INC (CNSP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.